A U.S. study showed that using Epstein-Barr virus-specific cytotoxic T lymphocyte treatment successfully prevented the development of EBV-lymphoma among hematopoietic stem cell transplant patients, who are considered at higher risk of developing the condition. The CTLs, which are specialized white blood cells, function by strengthening the body's defenses against illnesses.

Full Story:
New Kerala (India)

Related Summaries